National Cancer Institute and Gritstone bio team up on vaccine
Neoantigen vaccine candidate, SLATE-KRAS has demonstrated early evidence of efficacy
Read More
Tag: gritstone
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
